• Dec 04, 2006 | Webcast

    Assessment of Vitamin D Status

    Anthony Norman, Ph.D., Mark Haussler, Ph.D., Glenville Jones, Ph.D., Paul Lips, M.D., Ph.D., J. Wesley Pike, Ph.D., John Adams, M.D., Morten Nielsen
    Investigation of Metabolic Bone Diseases, Metabolic Bone Diseases, Integrative Physiology of the Skeleton

    Molecular Action of 1,25(OH)2
    Mark R. Haussler, Ph.D., University of Arizona College of Medicine, Phoenix, Arizona, USA

    Measurement of 25(OH)D (RIA, HPLC, LC/MS/MS) 
    Glenville Jones, Ph.D., Queen’s University, Kingston, Ontario, Canada

    The Relative Value of 25(OH)D and 1,25(OH)2D Measurements 
    Paul Lips, M.D., Ph.D., VU University Medical Center, Amsterdam, Netherlands

    Activation of Gene Expression by 1,25-Dihydroxyvitamin D3: Delineating Intracellular Mechanisms and Extracellular Influences Both In Vitro and In Vivo
    J. Wesley Pike, Ph.D., University of Wisconsin, Madison, Wisconsin, USA

    Substrate and Enzyme Trafficking as a Means of Regulating 1,25-Dihydroxyvitamin D Synthesis in Action
    John S. Adams, M.D., Cedars-Sinai Medical Center, Los Angeles, California, USA

    YOUNG INVESTIGATOR AWARD
    Prevalence of Vitamin D Insufficiency and Relationship with Peak Bone Mass in Young Men, Results from the Odense Androgen Study
    Morten F. Nielsen, Odense University Hospital, Odense, Denmark

    Supported by educational grants from Eli Lilly and Company, Merck & Co., Inc., NPS Pharmaceuticals, The Alliance for Better Bone Health (Procter & Gamble Pharmaceuticals and sanofi-aventis, US) and Immunodiagnostic Systems.

    Funding for this conference was made possible (in part) by Grant AR055036 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute on Aging, National Institute of Diabetes and Digestive and Kidney Diseases and the Office of Dietary Supplements. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

    Length: 146 minutes

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Policies and Procedures for more details